...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: prostate drug
https://en.m.wikipedia.org/wiki/Abiraterone We should know what successes original drugs have had with the idea from management our combo led IND will insure greater results leading to new treatment therapies and REVENUE / DIVIDENDS for shareholders of ZENITH CAPITOL CORP More reading info ... Thanks again Malisa ! Stock
Share
New Message
Please login to post a reply